Inclisiran—Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9

Dyslipidemia is listed among important cardiovascular disease risk factors. Treating lipid disorders is difficult, and achieving desirable levels of LDL-cholesterol (LDL-C) is essential in both the secondary and primary prevention of cardiovascular disease. For many years, statins became the basis o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wołowiec, Łukasz, Osiak, Joanna, Wołowiec, Anna, Wijata, Aleksandra, Grześk, Elżbieta, Kozakiewicz, Mariusz, Banach, Joanna, Nowaczyk, Alicja, Nowaczyk, Jacek, Grześk, Grzegorz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965021/
https://www.ncbi.nlm.nih.gov/pubmed/36839644
http://dx.doi.org/10.3390/pharmaceutics15020323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965021/
https://www.ncbi.nlm.nih.gov/pubmed/36839644
http://dx.doi.org/10.3390/pharmaceutics15020323

Ejemplares similares